These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

848 related items for PubMed ID: 20393589

  • 1. Oxidative stress and diabetic cardiovascular disorders: roles of mitochondria and NADPH oxidase.
    Shen GX.
    Can J Physiol Pharmacol; 2010 Mar; 88(3):241-8. PubMed ID: 20393589
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Vascular NAD(P)H oxidase activation in diabetes: a double-edged sword in redox signalling.
    Gao L, Mann GE.
    Cardiovasc Res; 2009 Apr 01; 82(1):9-20. PubMed ID: 19179352
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Effects of extensively oxidized low-density lipoprotein on mitochondrial function and reactive oxygen species in porcine aortic endothelial cells.
    Roy Chowdhury SK, Sangle GV, Xie X, Stelmack GL, Halayko AJ, Shen GX.
    Am J Physiol Endocrinol Metab; 2010 Jan 01; 298(1):E89-98. PubMed ID: 19843872
    [Abstract] [Full Text] [Related]

  • 8. Activation of nicotinamide adenine dinucleotide phosphate (reduced form) oxidase by advanced glycation end products links oxidative stress to altered retinal vascular endothelial growth factor expression.
    Li L, Renier G.
    Metabolism; 2006 Nov 01; 55(11):1516-23. PubMed ID: 17046555
    [Abstract] [Full Text] [Related]

  • 9. Diabetes and mitochondrial function: role of hyperglycemia and oxidative stress.
    Rolo AP, Palmeira CM.
    Toxicol Appl Pharmacol; 2006 Apr 15; 212(2):167-78. PubMed ID: 16490224
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Impact of mitochondrial ROS production on diabetic vascular complications.
    Nishikawa T, Kukidome D, Sonoda K, Fujisawa K, Matsuhisa T, Motoshima H, Matsumura T, Araki E.
    Diabetes Res Clin Pract; 2007 Sep 15; 77 Suppl 1():S41-5. PubMed ID: 17452060
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Nitric oxide dynamics and endothelial dysfunction in type II model of genetic diabetes.
    Bitar MS, Wahid S, Mustafa S, Al-Saleh E, Dhaunsi GS, Al-Mulla F.
    Eur J Pharmacol; 2005 Mar 21; 511(1):53-64. PubMed ID: 15777779
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The PPARgamma ligand, rosiglitazone, reduces vascular oxidative stress and NADPH oxidase expression in diabetic mice.
    Hwang J, Kleinhenz DJ, Rupnow HL, Campbell AG, Thulé PM, Sutliff RL, Hart CM.
    Vascul Pharmacol; 2007 Jun 21; 46(6):456-62. PubMed ID: 17337254
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Effect of apocynin on NADPH oxidase-mediated oxidative stress-LOX-1-eNOS pathway in human endothelial cells exposed to high glucose.
    Taye A, Saad AH, Kumar AH, Morawietz H.
    Eur J Pharmacol; 2010 Feb 10; 627(1-3):42-8. PubMed ID: 19878672
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 43.